Quidel (QDEL) has now received Emergency Use Authorization (EUA) from the US FDA for its Sofia 2 SARS Antigen FIA, a rapid point-of-care test for suspected COVID-19 infection. According to the FDA, this is a new category of tests that will now be available f…
Read More
Quidel’s Rapid Covid-19 Antigen Test Scores Emergency FDA Approval
